TBS publications

More than 1,600 peer-reviewed publications underpin Trabecular Bone Score^® (TBS^®) as the global standard in bone microarchitecture assessment.

Filter a curated database of publications below, or search PubMed for all TBS^® publications.

Filter by keyword:

2021

Journal of Clinical Densitometry

An Exploratory Study of the Texture Research Investigational Platform (TRIP) to Evaluate Bone Texture Score of Distal Femur DXA Scans – A TBS-Based Approach

White, R., Krueger, D., De Guio, F., Michelet, F., Hans, D., Anderson, P. and Binkley, N.

Orthopedics

2021

Journal of Clinical Densitometry

Ethnicity and Fracture Risk Stratification from Trabecular Bone Score in Canadian Women: The Manitoba BMD Registry

Leslie, W.D., Binkley, N. and Hans, D.

Fracture Risk Assessment

See the science in practice

We help clinicians reveal more from routine imaging — every patient, every scan — for better care.

Explore TBS Osteo Explore TBS Reveal Explore TBS Ortho

TBS Osteo™ is intended exclusively for healthcare professionals and is not available for purchase by the general public. TBS Osteo is a Class IIa medical device, CE marked under EU MDR 2017/745 (CE 2460). TBS Osteo is FDA 510(k) cleared (K243218) for use in the United States. TBS Osteo is included on the Australian Register of Therapeutic Goods (ARTG No. 528950) as "Inovanz Pty Ltd — X-ray system, diagnostic, general-purpose, application program software". Manufacturer: Medimaps Group SA, Chemin du Champ-des-Filles 36A, 1228 Plan-les-Ouates, Geneva, Switzerland. Always follow the instructions for use.

RBfracture™ is intended exclusively for healthcare professionals and is not available for purchase by the general public. RBfracture is a Class IIa medical device, CE marked under EU MDR 2017/745 (CE 0123). RBfracture is included on the Australian Register of Therapeutic Goods (ARTG No. 484605) as “Emergo Asia Pacific Pty Ltd T/a Emergo Australia - X-ray image interpretive software”. Manufacturer: Radiobotics ApS, Esplanaden 8C, 1tv, 1263, Copenhagen, Denmark. Always follow the instructions for use.

TBS Reveal™ is intended exclusively for healthcare professionals and is not available for purchase by the general public. TBS Reveal is a Class IIa medical device, CE marked under EU MDR 2017/745 (CE 2460). FDA clearance is pending; TBS Reveal is not available for clinical use in the United States. Manufacturer: Medimaps Group SA, Chemin du Champ-des-Filles 36A, 1228 Plan-les-Ouates, Geneva, Switzerland. Always follow the instructions for use.

TBS Ortho™ is currently under development and is not yet CE marked, FDA cleared, or otherwise registered for clinical use in any jurisdiction. It is not available for purchase or clinical use at this time.